Additional file 3 of Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response

Figshare 2026 Open access

Read full text
Authors: Albert Muñoz-Vendrell, Sergio Campoy-Díaz, Paloma Valín-Villanueva, Javier Casas‐Limón, Iris Fernández-Lázaro, Nuria González-García, Sonia Santos-Lasaosa, Yésica González Osorio, Alicia González‐Martínez, Jaume Campdelacreu, Leonardo Portocarrero-Sánchez, Luis Miguel Cano Sánchez
+20 more Sonia María García Sánchez, Alba Pérez-de-la-parte, Noemí Morollón Sánchez-Mateos, Alba López-Bravo, Ane Mínguez-Olaondo, Antonio Sánchez‐Soblechero, Alberto Lozano Ros, Cristian Morales Hernández, Alberto Andrés López, Almudena Layos-Romero, Edoardo Caronna, Marta Torres-Ferrús, Alicia Alpuente, Patricia Pozo‐Rosich, R. Belvís, David Garcia-Azorin, Javier Díaz de Terán, Ángel Luis Guerrero-Peral, Ana Beatriz Gago‐Veiga, Mariano Huerta-Villanueva
DOI: 10.6084/m9.figshare.30994894
Cited by: 0

Fields of Study & Subjects

Migraine and Headache Studies Urinary Bladder and Prostate Research Autoimmune Neurological Disorders and Treatments

Publication details

Journal / source
Figshare
Publication date
1 January 2026